Hoʻokumu ʻia ʻo Phosphite-Mediated Peptide Bond: Manaʻo kōkua no ka hoʻonui ʻana i nā hui paʻakikī
Papa helu

Pane wikiwiki

Gain proficient command of phosphite-mediated coupling chemistry tailored for sterically hindered amino acid residues in peptide synthesis. Grasp critical stereochemical control tactics, core risk points during process scale-up, and real-time analytical in-process control testing. These systematic technical measures effectively suppress side reactions, improve crude peptide purity and boost overall synthetic final yield for complex hindered peptide sequences.

Ma hope o ka pani ʻana o ka Peptide Science: Pehea e ʻimi ai nā Labs i nā mea hoʻolako ʻokoʻa BPC‑157

Hoʻonohonoho HPLC Analytical a me Mass Spectrometry no ka mana maikaʻi BPC-157

ʻO ka pani koke ʻana o ka Peptide Sciences - kahi lōʻihi o nā mea hoʻolaha nui o ʻAmelika ʻĀkau o nā peptides synthetic-grade noiʻi - ua hana i kahi hakahaka kūʻai nui ma waena o nā laboratories hoʻonaʻauao., nā mea hoʻomaka biotechnology, and contract research Cyclic Peptide organizations (Nā CRO). No nā mea noiʻi nui a me nā ʻepekema noiʻi e hoʻohana ana i ka BPC-157 (pentadecapeptide, kaʻina Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, kaumaha molekala 1419.55 A), hoʻopuka kēia pilikia i ka pilikia o ka hana.

ʻO ka hoʻololi ʻana i nā mea kūʻai aku ma waena o ke aʻo ʻana me ka ʻole o ka hōʻoia koʻikoʻi e hoʻoweliweli i ka hoʻomau hoʻokolohua. Hoʻopilikia pinepine ʻia nā peptides i hoʻololi ʻia i ka puʻupuʻu maʻemaʻe, pololei ʻole ka ʻike peptide net, koena trifluoroacetic acid (TFA) ʻawaʻawa, a me ka hōʻoia ʻole o ka ʻike. Ma nā ʻano moʻomeheu cell a i ʻole nā ​​bioassays holoholona, hoʻokomo kēia mau mea haumia i nā ʻano hoʻololi, ʻoihana makaʻala pohihihi, a hoʻopau i ka reproducibility ʻikepili.

E mālama i ka pono o ka noiʻi, Pono e ho'ololi i ke kū'ai 'ana mai ka mea kū'ai pasif a i ka mea hana, kaʻina hana hōʻoia hoʻolako analytical. Hāʻawi kēia alakaʻi i kahi papa helu loiloi loiloi-centric e uhi ana i ka loiloi palapala analytical, kumu hana, stoichiometry a me ke kūlana counter-ion, nā kinetics kūpaʻa, a me ka hoʻokō ʻana i ka waiwai naʻauao.


Pills 1: Palapala Analytical & Chromatographic Pono

ʻO ka pale mua e kū'ē i nā reagents noiʻi hikiʻole ke hana houʻia he laulā, hailona-specific Certificate of Analysis (KoA). Pono e hōʻole koke ʻia nā laʻana CoA maʻamau a i ʻole nā ​​​​palapala puʻupuʻu i nele i ka spectra analytical maka. Pono e hui pū ʻia nā moho āpau o BPC-157 e kēlā me kēia High-Performance Liquid Chromatography. (HPLC) a me Mass Spectrometry (MS) ʻikepili hoʻāʻo.

Hoʻololi-Phase HPLC (RP-HPLC) Hooia Maemae

ʻO RP-HPLC ke kūlana gula no ka helu ʻana i ka maʻemaʻe kemika a me ka ʻike ʻana i nā haumia peptide i ʻoki ʻia a hoʻololi ʻia.. I ka nānā ʻana i ka chromatogram HPLC o ka mea hoʻolako, hōʻoia i nā kūlana analytical:

  • Loaʻa hawewe ʻike: Pono e kiaʻi ʻia ka lawe ʻana o UV ma 214 nm a i ole 220 nm, e pili ana i ka apo absorption o ka peptide backbone amide bonds. ʻIke lōʻihi hawewe hoʻokahi ma 254 nm a i ole 280 ʻAʻole lawa ka nm no BPC-157 no ka mea ʻaʻole i loaʻa i ke kaʻina nā koena ʻala (e like me Tryptophan a i ʻole Tyrosine) e komo ikaika i nā lōʻihi hawewe UV kiʻekiʻe.
  • Kemimi kolamu: Pono e hoʻohana ka ʻikepili i kahi manawa kū i hoʻopaʻa ʻia no nā peptides, ʻO ka maʻamau he kolamu C18 hoʻohuli-phase (4.6 × 250 mm, 3.5 µm a i ʻole 5 µm nui ʻāpana, 120 Å nui pore).
  • ʻO ka Gradient Māhele Paʻa: Pono ka holo e hoʻohana i kahi gradient organik, maʻamau 0.1% TFA i ka wai ultra-maemae (Māhele Mobile A) i 0.1% TFA i ka HPLC-grade Acetonitrile (Mahele B).
  • Paepae ʻAe Maʻemaʻe: No nā noi noiʻi, ʻO ka nui o ka peptide peak integrated UV wahi e hōʻike i ka liʻiliʻi loa 98.0% o ka huina o na wahi piko i hoohuiia. E like me ka kikoʻī ma ka Nā Keʻena Hoʻāʻo Peptide ACS 2026 Alakaʻi hoʻopaʻa ʻana HPLC, helu ʻia ka pākēneka ʻāpana maʻemaʻe ma ka puʻunaue ʻana i ka ʻāpana kiʻekiʻe nui e ka huina o nā wahi piko i hoʻohui ʻia ma waena o ka leo ʻole a me ka holoi kolamu..
  • Nā ʻāpana Chromatographic: Pono ka piko nui e hōʻike i ka hoʻokaʻawale baseline me kahi kumu hoʻonā (Rₛ) o ka liʻiliʻi loa 1.5 pili i nā piko haumia pili, liʻiliʻi huelo (kumu asymmetry ma waena 0.8 a 1.2), a ʻaʻohe kumu hoʻoheheʻe e hūnā i nā ʻano like ʻole.

ʻIkepili Nui (MS) ʻIkepili & Ka Pono Nui

ʻOiai ka helu ʻana o HPLC i ka maʻemaʻe, ʻaʻole hiki ke hōʻoia i ka ʻike molekala. Pono ka nui spectrometry e hōʻoia e pili pono ka piko i hoʻomaʻemaʻe ʻia me BPC-157.

  • Ion Mass Kaulike: Electrospray Ionization Mass Spectrometry (ESI-MS) pono e hōʻike i kahi ʻano protonated hoʻokahi ma ka m/z 1420.55 [M+H]⁺ a me kekahi ʻano mea palua-protonated lua ma m/z 710.78 [M+2H]²⁺, pili i ka monoisotopic neutral mass o 1419.55 A.
  • Nā palena pololei o ka lehulehu: Pono e kūlike ka nuipa i ʻike ʻia i ka helu ʻana i loko o nā palena pololei:

    Δ m = ( |m ʻike ʻia - m theoretical|{m kuʻikahi} ) × 10⁶ ≤ 10 ppm

    Wahi a ka FormBlends 2026 Alakaʻi Nānā COA, kiʻekiʻe-resolution mass spectrometers (e like me Q-TOF a i ʻole nā ​​mea kani Orbitrap) pono e hoʻokō i nā hewa nui ma lalo 10 ppm, hōʻoia ʻana i ka haku mele pono.

  • Hōʻoia ʻo Tandem MS Sequence: No nā polokalamu koʻikoʻi in vivo a i ʻole ke alakaʻi maikaʻi ʻana, noi tandem MS (MS/MS) ʻāpana ʻāpana. ʻO ka hoʻokaʻawale ʻana i ka hui ʻana (CID) ʻāpana ʻāpana (b-ions a me y-ions) e hōʻoia i ke kaʻina o ka ʻakika amino pololei, ka hoʻokaʻawale ʻana i ka BPC-157 mai nā ʻano like ʻole isobaric scrambled.

⚠️ ʻŌlelo Aʻo: E makaʻala i nā mea hoʻolako e hoʻolako i nā chromatograms HPLC i ʻoki ʻia a i ʻole nā ​​​​mea kikoʻī nui i nele i nā lā kūʻai., mea kani helu serial, a i ʻole nā ​​helu hailona like. Pono e hoʻopili pono nā palapala analytical ʻoiaʻiʻo i ka faila ʻikepili maka i ka pahu pahu kikoʻī i hāʻawi ʻia i kāu keʻena.


ʻO kahi wahi maʻamau o ka huikau i ka hoʻomākaukau ʻana i ka peptide laboratory ka ʻokoʻa ma waena o ke kaumaha o ka pauka nui a me ka ʻikepili peptide net maoli.. ʻO ka loaʻa ʻana o kahi hue i kapa ʻia ʻo "5 mg BPC-157" ʻaʻole ia he manaʻo 5 mg o ka nui peptide ikaika. Best Peptides For Cancer Wholesale

al labeled “5 mg BPC-157” does not mean it contains 5 mg o ka nui peptide ikaika.

Ka helu ʻana i ka ʻiʻo Peptide Net (NPC)

ʻAʻole nā ​​​​hoʻomākaukau peptide Lyophilized 100% lāʻau lāʻau hana maʻemaʻe. Aia lākou i kahi hui o ka peptide ikaika, i hoʻopaʻa ʻia nā counter-ions, a me ka wai i koe. ʻO ka maʻiʻo Peptide Net (NPC) hōʻike i ka pākēneka maoli o ka nuipa peptide e pili ana i ka nui o ka pauka:

NPC (%) = ( Ka nui o ka Peptide Active Maʻemaʻe ) × 100%

Hoʻoholo maʻamau ka NPC me ka hoʻohana ʻana i ka Amino Acid Analysis (AAA) a i ʻole Elemental Nitrogen Analysis (N%). Ma nā ʻāpana lyophilized pāʻoihana, NPC ma waena 70% a 85%. ʻO ke koena 15% i 30% o ke kaumaha nui o:

  1. Wai Koe: Hoʻoholo ʻia ma o Karl Fischer (KF) titration; pono e noho nā pae kūpono ma lalo a i ʻole 8.0% (w/w).
  2. Ka-Iona: ʻO nā paʻakai i hōʻiliʻili ʻia i ka wā paʻa-phase synthesis a me ka cleavage.

Inā kaumaha ka mea noiʻi 1.0 mg o ka pauda lyophilized nui i manaʻo ʻia 100% peptide ikaika i ka wā o ka NPC maoli 75%, pau ka helu ana o ka mola i lalo 25%. This systematic under-dosing introduces substantial experimental error in quantitative SAR assays and cell

KA PALAPALA LYOPHILIZED MISS NET ACTIVE PEPTIDE MASS | | KAUKA- | (70% – 85%) | | Baysidepeptides NA IONA | Ala-Asp-Asp-Ala-Gly-Leu-Val | | Acetate) | (10% – 20%) WAI (KF) (≤ 8.0%)

ONS | Ala-Asp-Asp-Ala-Gly-Leu-Val | | Acetate) | (10% – 20%) WAI (KF) (≤ 8.0%)

Trifluoroacetate (TFA) ʻO ka ʻawaʻawa vs. Hoʻololi Acetate

ʻO ka peptide synthesis paʻa (SPSS) hoʻohana i ka trifluoroacetic acid (TFA) during resin cleavage and side-chain

Hoʻohuihui Peptide Pilikia Cytotoxic: Hiki i ke koena TFA counter-ions ke hoʻopau i ka moʻomeheu cell assays. ʻO ka nui o ka TFA e like me ka haʻahaʻa 0.1 Kāohi ʻo mM i ka hoʻonui ʻana o nā kelepona, hoʻololi i ka hiki o ka membrane, a hoʻoulu i ka cytotoxicity kikoʻī ʻole i nā laina kelepona mua a me nā kumu hoʻohālike organoid.

l, a hoʻoulu i ka cytotoxicity kikoʻī ʻole i nā laina kelepona mua a me nā kumu hoʻohālike organoid.

  • Koho Paakai: No ka in vitro cell assays and sensitive in vivo biological studies, Pono nā labs e noi i ka hoʻololi acetate a i ʻole ka paʻakai ʻole. I ka loiloi ʻana i nā mea kūʻai aku no nā noi kūikawā, hōʻoia inā hāʻawi lākou i hoʻolaʻa hana peptide maʻamau me ka hoʻopaʻa ʻia ʻana o ka TFA counter-ion (<1.0% ʻO ke koena maʻiʻo TFA i hōʻoia ʻia e Ion Chromatography).

Pills 3: Mea Hana Hana, ʻO ka maʻemaʻe, a me ka Mana Endotoxin

Ma hea a pehea e hana ʻia ai kahi peptide e kuhikuhi pololei i kona ʻano kino, kūpaʻa, a me ke kūʻokoʻa mai nā mea haumia olaola.

Hoʻokaʻawale lumi maʻemaʻe & Nā Mana Kaiapuni

ʻO ka Lyophilization a me ka hoʻopili ʻana e hōʻike i nā wahi hōʻike koʻikoʻi kahi e hiki ai i nā peptides sterile ke hoʻomoʻa i ka wai o ke kaiapuni a i ʻole nā ​​​​mea poke bacteria.. Pono nā mea hoʻolako ʻē aʻe e hōʻike i kēlā synthesis, ka hoomaemae ana, a hoʻopiha ʻia ka vial ma lalo o nā kūlana lumi hoʻomaʻemaʻe i kākau ʻia.

  • Papa 100 (ISO 5) Nā kūlana: Pono ka ʻeke aseptic i ka hana ʻana i loko o ka Papa 100 nā lumi hoʻomaʻemaʻe ultra-sterile, mālama ʻia me ka HEPA laminar ea kahe, puʻe maikaʻi mau, a me ka hoʻoponopono ʻana i ka mahana/māmā.
  • Pākuʻi & Nā Mana Microbe: Ke hana nei i loko o ka loiloi Papa 100 nā lumi hoʻomaʻemaʻe ultra-sterile hōʻoia i nā ʻāpana ea ambient (≥0.5 µm) noho malalo 3,520 nā ʻāpana no ka mika cubic, ka pale ʻana i ka spore fungal a i ʻole ka hoʻokomo ʻana i ka maʻi bacteria i ka wā o ka pani ʻana o ka hue.

ʻO ka hoʻāʻo ʻana i ka Endotoxin Bacterial (ʻIke LAL)

ʻO nā endotoxins bacteria (lipopolysaccharides, LPS) Hoʻokuʻu ʻia mai nā membrane waho Gram-negative i ka wā o ka fermentation bacteria a i ʻole ka holoi ʻana i ka wai i hoʻohaumia ʻia e hoʻoulu i nā cascades inflammatory koʻikoʻi i nā ʻōnaehana olaola..

  • Nā Koina Ho'āʻo LAL: ʻO kēlā me kēia pūʻulu i manaʻo ʻia no ka moʻomeheu cell a i ʻole ka noiʻi holoholona pono e loaʻa i ka quantitative Limulus Amebocyte Lysate (LAL) hoao ana.
  • Nā palena ʻae: ʻAʻole pono e ʻoi aku ka paepae endotoxin no ka pae noiʻi maʻamau 1.0 EU/mg. No ka hoʻokele makua koʻikoʻi a i ʻole nā ​​​​haʻawina immune cell, koho i nā pūʻulu i hōʻoia ʻia ma lalo a i ʻole 0.1 EU/mg.

Ki Takeaway: Maʻemaʻe HPLC kiʻekiʻe (>98%) ʻAʻole ia e hōʻoiaʻiʻo i nā pae endotoxin haʻahaʻa. ʻO nā endotoxins nā macromolecules ʻole-UV-absorbing ʻaʻole i hoʻopaʻa inoa ma nā ʻano RP-HPLC UV 214nm maʻamau.. Pono mau i nā hopena ho'āʻo LAL ma ka CoA.


Pills 4: Paʻa, Nā Kinetics mālama, a me nā hoʻomalu hoʻoponopono/IP

Hāʻawi kahi mea hoʻolako hilinaʻi i nā protocol kūpaʻa i hoʻopaʻa ʻia a hana ʻia ma lalo o nā ʻōnaehana hoʻokele maikaʻi maikaʻi e pale ai i kāu waiwai naʻauao..

Nā Kūʻai Kūʻai & Hoʻohana ʻana i nā Kūlana

ʻO ka hoʻomaopopo ʻana i nā kinetics degradation BPC-157 e hōʻoia i ka mālama ʻana o nā reagents i ka mana piha i nā haʻawina lōʻihi.:

  • Waihona Lyophilized: Desiccated lyophilized powder stored at -20°C to -80°C protected from light remains stable for at least 24 mahina. E pale i nā pōʻai maloʻo maloʻo ma mua o ka hoʻoponopono hou ʻana.
  • Nā Kinetics Hoʻohui Hou: Ke hoʻoheheʻe ʻia i loko o ka sterile, wai bacteriostatic deoxygenated a i ʻole saline phosphate-buffered (PBS, pH 7.4), paʻa ka wai BPC-157 ma 4°C no 14 i 28 lā.
  • Nā Vector Hoʻohaʻahaʻa Kemika: Aia ka BPC-157 i ka Aspartate-Aspartate (Asp-Asp) a me nā kumu waiwai Proline. Hōʻike i nā wela kiʻekiʻe (>25°C), pH alkaline (>8.0), a i ʻole nā ​​kaiapuni oxidizing e hoʻolalelale i nā ala hoʻohaʻahaʻa kikoʻī:
    1. Deamidation: Hoʻokumu ʻia ʻo Isoaspartate ma nā kahua Asp-Asp, hoʻololi i ka manawa paʻa ma HPLC.
    2. ʻO ka hoʻokaʻawale proline: ʻO Cis-trans conformational flipping e hoʻololi i nā kinetics hoʻopaʻa paʻa i ka mea hoʻokipa.
    3. Huihui: ʻO ka hui hydrophobic e hana ana i nā oligomers insoluble ma lalo o ka ikaika ionic kiʻekiʻe.

Hooponopono Hooponopono & Palekana Waiwai Naauao

I ka wā e koho ai i kahi mea hoʻolako ʻokoʻa, hoʻoponopono i kā lākou mau ʻōnaehana maikaʻi a me nā pale kānāwai:

  1. ʻO ka hōʻoia maikaʻi: Hoʻonohonoho mua i nā mea hana e hana ana ma lalo o ISO 9001:2015 ʻōnaehana hoʻokele maikaʻi a i ʻole ISO/IEC 17025 hale hana analytical accredited.
  2. ʻO ka hiki ke hoʻopaʻa ʻia: Pono ka mea hana e mālama i nā lāʻau hoʻopaʻa paʻa paʻa, resin lot tracking, a me nā palapala hoʻomaʻemaʻe solvent.
  3. Hoʻolaha Mana Hoʻololi: Pono nā mea hoʻolako e ʻae i nā Hoʻolaha Mana Hoʻololi (CCN) ma mua o ka hoʻololi ʻana i nā ala synthesis, mea hoʻomaʻemaʻe, a i ʻole nā ​​wahi hale hana.
  4. Palekana Waiwai Naauao: E hōʻoia i ka hāʻawi ʻana o ka mea hoʻolako i nā ʻaelike Hōʻike ʻole i pūlima ʻia (Nā NDA) a maopopo nā ʻaelike hoʻoili waiwai (MTA) e pale ana i ka hoʻololi ʻana i ke kaʻina hana a me ka ʻikepili noiʻi. E like me ka mea i hōʻike ʻia ma ka DosingCalc 2026 Nā Kūlana hoʻāʻo maikaʻi ʻo Peptide, hana pū me nā hoa hāʻawi nā lawelawe peptide CRO kūikawā hōʻoiaʻiʻo i ka kuleana IP a me ka hoʻokō hoʻoponopono no nā papahana synthesis maʻamau.

Papa Hoʻoponopono Loiloi o ka Mea Hana Hana Hana Hana

E hoʻohana i kēia papa helu loiloi binary i ka wā o ka loiloi mea kūʻai ʻenehana. Pono kēlā me kēia mea hoʻolako moho e hoʻokō a ʻoi aku paha ma mua o ka ʻae ʻana ma mua o ka loaʻa ʻana o ka ʻae kūʻai.

Māhele Hooia Helu Loiloi Hōʻike ʻae ʻia Keʻano hōʻoia Kūlana
1. QC hōʻike RP-HPLC Wahi Maʻemaʻe ≥98.0% wahi hui puʻu nui UV 214nm / C18 Column Chromatogram [ ] P

High-Res Mass Hale Hana Hana Hoʻohui Peptide Synthetic Spectrum

td colspan=”1″ rowspan=”1″>

1. QC hōʻike

ESI-MS Hoʻopaʻa Nui [M+H]⁺ = 1420.55 ±0.01 Da (Hapa Nui ≤10 ppm) Kiʻekiʻe-Res Mass Spectrum [ ] Holo / hāʻule
1. QC hōʻike Chromatographic Symmetry Re

Peak Shape Pentapeptide 4 Analysis

ailing Factor 0.8–1.2

Nānā Kiʻi Kiʻekiʻe [ ] Holo / hāʻule
2. Stoichiometry Maʻiʻo Peptide Net (NPC) Hōʻike maopopo ʻia (ʻO ka maʻamau 70%–85%) ʻIkepili ʻAmina Amino (AAA) a i ʻole N% [ ] Holo / hāʻule
2. Stoichiometry Māmā Karl Fischer Titration ≤8.0% w/w Hōʻike KF Analytical [ ] Holo / hāʻule
2. Stoichiometry ʻIke Kūʻē-Ion Hōʻike ʻia (TFA, Acetate, a i ʻole ke kahua kūʻokoʻa); TFA koena <1.0% no ka hoʻāʻo ʻana i ke kelepona Ion Chromatography [ ] Holo / hāʻule
3. Hana ʻana Kaiapuni lumi maʻemaʻe Papa 100 (ISO 5) kaiapuni sterile Log Hooia Kaiapuni / Cert [ ] Holo / hāʻule
3. Hana ʻana Ka palena Endotoxin ʻIke LAL ≤1.0 EU/mg (≤0.1 EU/mg no ka noiʻi holoholona) Palapala Hoao LAL [ ] Holo / hāʻule
4. Paʻa/IP Nā Kūlana Waihona i kākau ʻia Hoʻopaʻa ʻia lyophilized (-20°C) a me ka hoʻonā (4°C) ʻikepili Hōʻuluʻulu Haʻawina Paʻa [ ] Holo / hāʻule
4. Paʻa/IP QA & Hiki ke ʻimi ʻO ka lepili pahu hoʻohālike CoA kikoʻī nui; ISO 9001/17025 ʻIkepili Maka & QA hōʻailona [ ] Holo / hāʻule

Ke Kaʻina Hana Hoʻoholo: Loaʻa a me ka hoʻokolo ʻana i nā pani pani BPC-157

E hahai i kēia protocol maʻamau i ka loaʻa ʻana o nā mea hoʻouna mai kahi mea kūʻai peptide hou:

  • ʻanuʻu 1: Kikino & Hooia Packaging → Nānā i nā sila vial, lyophilized keke kūlike, a hōʻoia i nā helu hailona e pili ana i nā pepa hoʻouna a me CoA.
  • ʻanuʻu 2: Hooia Palapala Analytical → E hōʻoia i ka loaʻa ʻana o nā chromatograms RP-HPLC UV 214nm piha (maʻemaʻe ≥98.0%) a me ESI-MS spectra (m/z 1420.55 M+H⁺, hewa nui ≤10 ppm). E hōʻoia i ka hopena endotoxin LAL (≤1.0 EU/mg).
  • ʻanuʻu 3: Helu Stoichiometric → E nānā i ka ʻikepili Net Peptide i hōʻike ʻia (NPC %). E helu i ka nuipa maoli i koi ʻia no nā haʻina mola i manaʻo ʻia:

    Kaumaha Koʻikoʻi = makemake ʻia ka Peptide Mass/NPC Decimal

  • ʻanuʻu 4: Hoao Hoao & Hōʻike Hōʻole → Hoʻohui hou i loko o ka mea hoʻoheheʻe sterile. Inā hōʻike ka haʻina i ka turbidity, nā ʻōpala hoʻomau, a i ʻole ka hoʻokaʻawale pH (<5.0 a i ʻole >8.0), hoʻopau koke i ka hoʻohana ʻana a hoʻopuka i kahi hōʻike hōʻike maikaʻi loa.

Nīnau pinepine (FAQ)

He aha ka maʻemaʻe HPLC liʻiliʻi loa no ka BPC-157 i nā bioassays noiʻi?

No nā haʻawina biochemical quantitative, hoʻopaʻa hoʻopaʻa hoʻopaʻa ʻana i ka mea hoʻokipa, a me nā hiʻohiʻona moʻomeheu cell, ʻo ka maʻemaʻe liʻiliʻi e ʻae ʻia 98.0% e like me ka mea i hoʻoholo ʻia e RP-HPLC me ka ʻike UV ma 214 nm. Nā pae maʻemaʻe ma lalo 98% Loaʻa i nā peptides ʻokiʻoki synthetic a i ʻole nā ​​​​sequence hemahema e hiki ai ke hoʻokūkū paʻa i nā mea loaʻa, e alakaʻi ana i nā hopena hoʻokolohua kuhi hewa ʻole.

No ke aha i ʻokoʻa ai ke kaumaha o ka vial mai ka ʻupena BPC-157 peptide content?

Loaʻa i nā pauka peptide Lyophilized nā ʻāpana non-peptide, e komo pū me nā counter-ions i hoʻopaʻa ʻia (e like me TFA a i ʻole acetate) hōʻiliʻili ʻia i ka wā synthesis a me ke koena o ka wai i hoʻopaʻa ʻia i ka wā o ka lawelawe ʻana. ʻO ka maʻiʻo Peptide Net (NPC) hōʻike i ka pākēneka maoli o ka nui peptide ikaika i loko o ka paona pauda (maʻamau 70% i 85%). E hoʻololi mau i ka helu ʻana me ka hoʻohana ʻana i ka waiwai NPC kikoʻī i hōʻike ʻia ma ka CoA.

Pehea ka hopena o ke koena TFA i nā hoʻokolohua moʻomeheu cell?

ʻAka Trifluoroacetic (TFA) he ʻakika organik ikaika i hoʻohana ʻia i ka wā paʻa-phase peptide synthesis. Hiki i ke koena TFA counter-ions i loko o ka hoʻomākaukau ʻana i ka peptide i hoʻololi ʻole ʻia ke hoʻohaʻahaʻa i ka pH media moʻomeheu a hoʻokau pololei i nā hopena cytotoxic i nā cell ma nā ʻano ma luna. 0.1 mM. No ka moʻomeheu cell, pūʻali pū, a i ʻole nā ​​haʻawina organoid, e kuhikuhi i ka acetate-exchanged a i ʻole ka paʻakai-ʻole BPC-157 me nā pae TFA i hōʻoia ʻia ma lalo 1.0%.

He aha nā palapala e hōʻike ana i kahi mea kūʻai aku i ka paʻa paʻa ʻana o ka hui?

E ʻimi i nā mea hoʻolako e hana ana ma lalo o ISO 9001:2015 nā kūlana hoʻokele maikaʻi a i ʻole ISO/IEC 17025 hōʻoia ʻana o ka hale hana. Hāʻawi nā mea hana kaulana i nā chromatograms overlay lot-to-lot, mālama i ka traceability piha maka, a hoʻopuka i nā Hoʻolaha Mana Mana Hoʻololi ma mua o ka hoʻololi ʻana i nā kaʻina hana synthetic a i ʻole nā ​​ʻāpana hoʻopili.


E hooikaika ana i na Laa Hana Hana Hana Hana

ʻO ka hoʻokele ʻana i ka hoʻopau ʻana i nā kaulahao lako ma hope o ka pani ʻana o ka mea kūʻai aku e pono ai i kahi kūpaʻa kūpaʻa i ka ʻano loiloi.. Ma ka hoʻokō ʻana i kahi kauoha, papa helu loiloi loiloi he nui—hoʻomua i ka maʻemaʻe RP-HPLC, ʻike ESI-MS kiʻekiʻe, ka helu ʻana i ka Net Peptide Content, Papa 100 lumi hoʻomaʻemaʻe kumu, a me ka hoʻāʻo ʻana o ka endotoxin LAL—hiki i nā keʻena noiʻi ke hoʻokō pono i nā mea hoʻolako BPC-157 ʻē aʻe i ka wā e mālama ana i ka pono ʻikepili a me ka hana hou ʻana i ka hoʻokolohua..

No nā hui noiʻi e ʻimi nei i nā peptides maʻemaʻe kiʻekiʻe, palapala analytical ikaika, a Papa 100 hale hana maʻemaʻe, hoapili me kahi paepae synthesis i hoʻopaʻa ʻia. E ʻimi nā hoʻonā peptide synthesis maʻamau a i ʻole e kūkākūkā me nā loea loea e hoʻokumu i nā kaulahao lako i hōʻoia ʻia no kāu mau papahana noiʻi.


No ka mea kakau & Nānā ʻenehana

Kakau ia e ka Scientific & Pūʻulu hōʻoia maikaʻi ma nā hoʻololi MOL
ʻO MOL Changes kahi R&ʻO ka hui D e hoʻohui ana i ka kemika organik a me ka loea biology molecular. Papa hana i hooiaioia 100 nā wahi lumi hoʻomaʻemaʻe ultra-sterile, ʻO kā mākou hui o nā peptide synthesis chemists a me nā loea analytical e hoʻolālā i nā protocol sequence maʻamau, hoʻokele i nā kahe hana fermentation solid-phase a me ka microbial, a hana i ka HPLC piha, MS, a me ka mana maikaʻi o ka endotoxin no nā keʻena noiʻi hoʻonaʻauao a me ka ʻenehana ma ka honua holoʻokoʻa.

Miao He

Miao He

ʻepekema noiʻi ma nā ʻōnaehana hoʻouna Kaʻike kumu: Hāʻawi peptide waha, lipid nanoparticle (LNP) hoʻopili ʻana, nā peptides komo i loko o ke kelepona (CPPs), a me nā hoʻopuka hoʻokuʻu mau.

Pilikino: ʻO nā luʻi nui i ka hoʻomohala ʻana i nā lāʻau peptide aia i loko o ko lākou mau hapalua ola pōkole a paʻakikī me ka hoʻokele waha, a ʻo Miao ʻO ia kekahi loea alakaʻi i ka hoʻoponopono ʻana i kēia mau pilikia. Loaʻa iā ia ka ʻike nui ma ke kahua o nā ʻōnaehana lawe peptide. Ke hoʻomau nei ʻo ia i ka hoʻomohala ʻana i nā mea hoʻonui permeation novel a me nā nanospheres e hoʻomaikaʻi nui i ka bioavailability o peptides..

ʻIke ʻia & Nā alakaʻi hoʻoponopono
Nānā ʻia e: Ka poe akamai kumuhana
Kaʻana like i kēia ʻatikala
Home Huli Whatsapp Nā lawelawe Huahana